Multiple Myeloma

Daratumumab, a monoclonal antibody drug, significantly reduces the risk of progression to active multiple myeloma and improves overall survival compared to active monitoring.

An overview of the 10 most popular articles Mayo Clinic Comprehensive Cancer Center Blog published in 2024.

Mayo Clinic Comprehensive Cancer Center researchers spent 2024 mining patient data, leveraging artificial intelligence and conducting clinical trials to reveal insights that improve patient care.

Over 25 years as a Mayo Clinic patient, Ann Mackey finds answers, treatment for multiple bouts of cancer, and a way to give back.

Dr. Sikander Ailawadhi says physicians are identifying, monitoring and eliminating blood cancer earlier thanks to new treatments.

Read about the research being conducted to improve CAR-T cell therapy and expand its capabilities to treat more conditions.

Researchers have uncovered a new reason CAR-T cell therapy fails in some patients, fueling new strategies to improve the treatment's outcome.

Dr. Joselle Cook explains how recent advances in treatment are helping people with multiple myeloma live longer.

After receiving CAR-T cell therapy at Mayo Clinic, Welsh-born John Cadwallader achieved remission and found new hope. He now receives care in the U.K. and is monitored by Mayo in the U.S. and London.

Dr. Joselle Cook discusses how multiple myeloma evolves, its treatment and research into screening methods.